BIM
GNMK

BlackRock Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

BlackRock Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.96M Buy
160,182
+583
+0.4% +$6.92K ﹤0.01% 2228
2016
Q3 		$1.88M Buy
159,599
+5,505
+4% +$53.1K ﹤0.01% 2204
2016
Q2 		$1.34M Buy
154,094
+3,899
+3% +$26.7K ﹤0.01% 2412
2016
Q1 		$792K Buy
150,195
+2,837
+2% +$15.8K ﹤0.01% 2639
2015
Q4 		$1.14M Buy
147,358
+834
+0.6% +$6.41K ﹤0.01% 2496
2015
Q3 		$1.15M Sell
146,524
-3,759
-3% -$34.8K ﹤0.01% 2502
2015
Q2 		$1.36M Buy
150,283
+28,892
+24% +$291K ﹤0.01% 2536
2015
Q1 		$1.58M Buy
121,391
+995
+0.8% +$13K ﹤0.01% 2198
2014
Q4 		$1.64M Sell
120,396
-625
-0.5% -$6.99K ﹤0.01% 2181
2014
Q3 		$1.09M Buy
121,021
+1,490
+1% +$16K ﹤0.01% 2472
2014
Q2 		$1.62M Buy
119,531
+20,255
+20% +$211K ﹤0.01% 2253
2014
Q1 		$987K Buy
99,276
+1,809
+2% +$22.5K ﹤0.01% 2513
2013
Q4 		$1.29M Sell
97,467
-1,902
-2% -$23.1K ﹤0.01% 2318
2013
Q3 		$1.21M Buy
99,369
+23,932
+32% +$257K ﹤0.01% 2311
2013
Q2 		$781K Buy
+75,437
New +$1.04M ﹤0.01% 2543

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Investment Management's GNMK Position: Q4 2016 in Review

BlackRock Investment Management increased its GenMark Diagnostics, Inc (GNMK) stake by 0.37% in Q4 2016, buying an estimated $6.92K and bringing the position to 160,182 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

BlackRock Investment Management first reported a position in GNMK in Q2 2013 and has held it in 15 quarters since. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

  • BlackRock Investment Management held 160,182 shares of GenMark Diagnostics, Inc worth $1.96M as of Q4 2016.
  • BlackRock Investment Management bought 583 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $6.92K.
  • GenMark Diagnostics, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2228 holding.
  • BlackRock Investment Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 15 quarters since.
  • 90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.